Concepedia
Statistics
Publications
10
Citations
586
H-Index
Active since
2010
Affiliations
Erasmus MC(Current)
Erasmus MC Cancer Institute
Erasmus University Rotterdam
Max Planck Institute for Molecular Genetics
Utrecht University
Marijn T. M. van Jaarsveld is an author at Erasmus MC specializing in oncology, molecular oncology, and medicine.
Publications per year
2010–2020
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells
Marijn T. M. van Jaarsveld, Jozien Helleman, Antonius W.M. Boersma et al. · Oncogene · 2012 · 220 citations
Medicine, Molecular Biology, Oncology +16
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway
Marijn T. M. van Jaarsveld, Patricia F. van Kuijk, Antonius W.M. Boersma et al. · Molecular Cancer · 2015 · 77 citations · Full text
Medicine, Oncology, Pharmacology +17
MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines
Katharina Uhr, Wendy J. C. Prager‐van der Smissen, Anouk A. J. Heine et al. · PLoS ONE · 2019 · 69 citations · Full text
Medicine, Oncology, Pharmacology +11
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity
Marijn T. M. van Jaarsveld, Maikel D. Wouters, Antonius W.M. Boersma et al. · Molecular Oncology · 2013 · 48 citations · Full text
Life Sciences, Molecular Biology, Oncology +17
Lysophospholipids secreted by splenic macrophages induce chemotherapy resistance via interference with the DNA damage response
Julia M. Houthuijzen, Laura G.M. Daenen, Jeanine M.L. Roodhart et al. · Nature Communications · 2014 · 47 citations · Full text
Life Sciences, Immunology, Oncology +16
1–5 of 10